We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Subsidiary Warned for Drug Quality Concerns
Pfizer Subsidiary Warned for Drug Quality Concerns
The FDA issued a warning to Pfizer subsidiary Hospira Healthcare India for contamination risks, out-of-specification batches and other violations observed at its Chennai, Tamil Nadu facility.